• Series Overview
• Program Content
• Faculty
• Target Audience
• Learning Objectives
• CPE Credit
• Recertification Credit
• Technical Requirements

The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners read and analyze the articles and view the online presentation, they must successfully complete an online assessment to earn recertification credit.

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities (see table below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.

Module 1A – Antithrombotics/Antiplatelets: This module focuses on antithrombotic therapy in patients with heart failure and atrial fibrallation, as well as antiplatelet therapy in patients with diabetes mellitus.

Module 1B – Critical Care Cardiology and Endocarditis: This module focuses on the use of epinephrine in cardiac arrest and cardiogenic shock, as well as the partial use of oral antibiotic therapy in endocarditis.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ASHP and ACCP professional development program for BCCP recertification approved by the BPS.

Steven Dunn, Pharm.D., BCPS-AQ Cardiology, FAHA, FCCP* 
Pharmacy Clinical Coordinator, Heart & Vascular
University of Virginia Health System
Charlottesville, Virginia

Genevieve M. Hale, Pharm.D., BCPS 
Assistant Professor
Nova Southeastern University College of Pharmacy
Palm Beach Gardens, Florida

Tracy Macaulay, Pharm.D., BCCP, BCPS - AQ Cardiology, AACC* 
Tracy Macaulay, Pharm.D., BCCP, BCPS - AQ Cardiology, AACC*
Cardiology Clinical Specialist
UKHealthCare and Gill Heart Institute
Lexington, New York

Zachary R. Noel, Pharm.D., BCCP, BCPS 
Assistant Professor
University of Maryland School of Pharmacy
Baltimore, Maryland

Brent Reed, Pharm.D., BCPS-AQ Cardiology, FAHA* 
Associate Professor, Pharmacy Practice and Science
University of Maryland School of Pharmacy
Baltimore, Maryland

* Content Matter Experts

The Cardiology Pharmacy Specialty Literature Study is designed to help board-certified pharmacy practitioners who are seeking recertification credit hours to maintain their Board of Pharmacy Specialties (BPS) Board Certification.

Module 1A: Antithrombotics/Antiplatelets

• Explain the rationale, methodology, findings, limitations, and implications of the COMMANDER HF study of rivaroxaban use in patients with recent worsening of chronic heart failure, reduced left ventricular ejection fraction, sinus rhythm, and coronary artery disease without atrial fibrillation.
• Formulate recommendations for the use of rivaroxaban in patients with recent worsening of chronic heart failure and reduced ejection fraction due to ischemic heart disease without atrial fibrillation.
• Explain the changes since 2016 in the 2018 updated focused expert consensus recommendations for antithrombotic therapy in patients with atrial fibrillation (AF) treated with oral anticoagulation (OAC) who have undergone percutaneous coronary intervention (PCI) and stent placement
• Formulate recommendations for the use of antithrombotic therapy in patients with atrial fibrillation (AF) treated with oral anticoagulation (OAC) who have undergone percutaneous coronary intervention (PCI) and stent placement.
• Explain the rationale, methodology, findings, limitations, and implications of A Study of Cardiovascular Events in Diabetes (ASCEND), which assessed the efficacy and safety of aspirin for primary prevention of cardiovascular events in patients with diabetes mellitus.
• Formulate recommendations for primary prevention of cardiovascular events in patients with diabetes mellitus.

Module 1B: Critical Care Cardiology and Endocarditis

• Explain the rationale, methodology, findings, limitations, and implications of the PARAMEDIC2 study of epinephrine treatment for out-of-hospital cardiac arrest.
• Formulate recommendations for the use of epinephrine in adults with out-of-hospital cardiac arrest.
• Explain the rationale, methodology, findings, limitations, and implications of the OptimaCC study comparing the efficacy and tolerability of epinephrine with norepinephrine in adults with cardiogenic shock after acute myocardial infarction and successful revascularization through percutaneous coronary intervention.
• Formulate recommendations for the use of vasopressors in adults with cardiogenic shock after acute myocardial infarction.
• Explain the rationale, methodology, findings, limitations, and implications of the Partial Oral Treatment of Endocarditis (POET) study.
• Formulate recommendations for the route of administration of antibiotic therapy for adults with left-sided infective endocarditis.

The American Society of Health-System Pharmacists and American College of Clinical Pharmacy are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by April 24, 2022.

Board certified pharmacists are eligible to receive up to 8 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by October 22, 2019. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Requires an Internet browser and Adobe Reader.